Alembic Pharmaceuticals Limited announces USFDA Final Approval for Lamotrigine Orally Disintegrating Tablets USP, 25 mg, 50 mg, 100 mg and 200 mg. Read more
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Efinaconazole Topical Solution Read more
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Difluprednate Ophthalmic Emulsion Read more
Akums Strengthens Presence in Regulated Markets with EU GMP Approvals for 2 Haridwar Plants Read more
Venus Remedies Receives Second PLI Incentive Disbursement, Reinforcing Manufacturing Strength Read more
FIRST GENERIC APPROVAL: VENUS REMEDIES SECURES MARKETING AUTHORISATION FOR CEFTAZIDIME + AVIBACTAM IN INDONESIA Read more